Stephan A. Mayer - Concepedia

Author

Stephan A. Mayer

Also Known As

Adam G. Kelly, Angela Velazquez, Geoffrey S. F. Ling, Gurmeen Kaur, J. Chong, Jan Claassen, K. R. Lees, Kiwon Lee, Lattanzi, Simona, Marcello Massimini

764

Publications

47.8K

Citations

115

H-Index

151

Concepts

All Affiliations

Columbia University Neurological Surgery Columbia University Irving Medical Center NewYork–Presbyterian Hospital New York Medical College

About

Stephan A. Mayer is an author at Columbia University specializing in medicine, neurology, and brain injury.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	47	99	6.9K
2	Health Sciences	15	16	1.4K
3	Public Health	14	15	1.2K
4	Engineering	3	3	217
5	Language Studies	1	1	159

Stephan A. Mayer

314

Publications

35.4K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage Stephan A. Mayer, Nikolai C. Brun, Kamilla Begtrup, New England Journal of Medicine	2008	1.2K
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage Stephan A. Mayer, Nikolai C. Brun, Kamilla Begtrup, New England Journal of Medicine	2005	1.2K
Prediction of Symptomatic Vasospasmafter Subarachnoid Hemorrhage: The Modified Fisher Scale Jennifer Frontera, Jan Claassen, J. Michael Schmidt, Neurosurgery	2006	849
Effect of Cisternal and Ventricular Blood on Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: Jan Claassen, Gary L. Bernardini, Kurt T. Kreiter, Stroke	2001	728
Refractory Status Epilepticus Stephan A. Mayer, Jan Claassen, Johnny K Lokin, Archives of Neurology	2002	647
Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) R. Loch Macdonald, Neal F. Kassell, Stephan A. Mayer, Stroke	2008	626
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) R. Loch Macdonald, Randall T. Higashida, E. Keller, The Lancet Neurology Placebo-controlled Phase 3Endovascular TechniqueVascular SurgeryNeurologyNeurovascular Disease	2011	625
Impact of medical complications on outcome after subarachnoid hemorrhage* Katja E. Wartenberg, J. Michael Schmidt, Jan Claassen, Critical Care Medicine	2006	587
A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC) Gregory W. J. Hawryluk, Sergio Aguilera, András Büki, Intensive Care Medicine	2019	573
Defining Vasospasm After Subarachnoid Hemorrhage Jennifer Frontera, Andres Fernandez, J. Michael Schmidt, Stroke	2009	569

Page 1